Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy

BACKGROUND: Selecting the appropriate patients to receive immunotherapy (IO) remains a challenge due to the lack of optimal biomarkers. The presence of liver metastases has been implicated as a poor prognostic factor in patients with metastatic cancer. We investigated the association between sites o...

Descripción completa

Detalles Bibliográficos
Autores principales: Bilen, Mehmet Asim, Shabto, Julie M., Martini, Dylan J., Liu, Yuan, Lewis, Colleen, Collins, Hannah, Akce, Mehmet, Kissick, Haydn, Carthon, Bradley C., Shaib, Walid L., Alese, Olatunji B., Steuer, Conor E., Wu, Christina, Lawson, David H., Kudchadkar, Ragini, Master, Viraj A., El-Rayes, Bassel, Ramalingam, Suresh S., Owonikoko, Taofeek K., Harvey, R. Donald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716879/
https://www.ncbi.nlm.nih.gov/pubmed/31464611
http://dx.doi.org/10.1186/s12885-019-6073-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716879/
https://www.ncbi.nlm.nih.gov/pubmed/31464611
http://dx.doi.org/10.1186/s12885-019-6073-7

Ejemplares similares